Safety and efficacy of abemaciclib plus endocrine therapy in older patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: an age-specific subgroup analysis of MONARCH 2 and 3 trials
Goetz, Matthew P., Okera, Meena, Wildiers, Hans, Campone, Mario, Grischke, Eva-Maria, Manso, Luis, André, Valérie A. M., Chouaki, Nadia, San Antonio, Belén, Toi, Masakazu, Sledge, George W.
Published in Breast cancer research and treatment (01.04.2021)
Published in Breast cancer research and treatment (01.04.2021)
Get full text
Journal Article
Abemaciclib as initial therapy for advanced breast cancer: MONARCH 3 updated results in prognostic subgroups
Johnston, Stephen, O'Shaughnessy, Joyce, Martin, Miguel, Huober, Jens, Toi, Masakazu, Sohn, Joohyuk, André, Valérie A M, Martin, Holly R, Hardebeck, Molly C, Goetz, Matthew P
Published in NPJ breast cancer (22.06.2021)
Published in NPJ breast cancer (22.06.2021)
Get full text
Journal Article
Abemaciclib in combination with endocrine therapy for East Asian patients with HR+, HER2− advanced breast cancer: MONARCH 2 & 3 trials
Toi, Masakazu, Inoue, Kenichi, Masuda, Norikazu, Iwata, Hiroji, Sohn, Joohyuk, Hae Park, In, Im, Seock‐Ah, Chen, Shin‐Cheh, Enatsu, Sotaro, Turner, P. Kellie, André, Valérie A. M., Hardebeck, Molly C., Sakaguchi, Sachi, Goetz, Matthew P., Sledge, George W.
Published in Cancer science (01.06.2021)
Published in Cancer science (01.06.2021)
Get full text
Journal Article
Phase I Study of Docetaxel in Combination with the P-Glycoprotein Inhibitor, Zosuquidar, in Resistant Malignancies
FRACASSE, Paula M, GOLDSTEIN, Lori J, BURGESS, Michael F, SLAPAK, Christopher A, SCHELLENS, Jan H. M, DE ALWIS, Dinesh P, RADER, Janet S, ARQUETTE, Matthew A, GOODNER, Sherry A, WRIGHT, Lisa P, FEARS, Carole L, GAZAK, Robert J, ANDRE, Valerie A. M
Published in Clinical cancer research (01.11.2004)
Published in Clinical cancer research (01.11.2004)
Get full text
Journal Article
Management of Abemaciclib‐Associated Adverse Events in Patients with Hormone Receptor‐Positive, Human Epidermal Growth Factor Receptor 2‐Negative Advanced Breast Cancer: Safety Analysis of MONARCH 2 and MONARCH 3
Rugo, Hope S., Huober, Jens, García‐Sáenz, José A., Masuda, Norikazu, Sohn, Joo Hyuk, Andre, Valerie A.M., Barriga, Susana, Cox, Joanne, Goetz, Matthew
Published in The oncologist (Dayton, Ohio) (01.03.2021)
Published in The oncologist (Dayton, Ohio) (01.03.2021)
Get full text
Journal Article
Real-world survival outcomes of heavily pretreated patients with refractory HR+, HER2−metastatic breast cancer receiving single-agent chemotherapy—a comparison with MONARCH 1
Rugo, Hope S., Dieras, Veronique, Cortes, Javier, Patt, Debra, Wildiers, Hans, O’Shaughnessy, Joyce, Zamora, Esther, Yardley, Denise A., Carter, Gebra Cuyun, Sheffield, Kristin M., Li, Li, Andre, Valerie A. M., Li, Xiaohong I., Frenzel, Martin, Huang, Yu-Jing, Dickler, Maura N., Tolaney, Sara M.
Published in Breast cancer research and treatment (01.11.2020)
Published in Breast cancer research and treatment (01.11.2020)
Get full text
Journal Article
Oral Administration of Gemcitabine in Patients with Refractory Tumors: A Clinical and Pharmacologic Study
Veltkamp, Stephan A, Jansen, Robert S, Callies, Sophie, Pluim, Dick, Visseren-Grul, Carla M, Rosing, Hilde, Kloeker-Rhoades, Susanne, Andre, Valerie A M, Beijnen, Jos H, Slapak, Christopher A, Schellens, Jan H M
Published in Clinical cancer research (01.06.2008)
Published in Clinical cancer research (01.06.2008)
Get full text
Journal Article
Management of Abemaciclib‐Associated Adverse Events in Patients with Hormone Receptor‐Positive, Human Epidermal Growth Factor Receptor 2‐Negative Advanced Breast Cancer: Safety Analysis of MONARCH 2 and MONARCH 3
Rugo, Hope S., Huober, Jens, García‐Sáenz, José A., Masuda, Norikazu, Sohn, Joo Hyuk, Andre, Valerie A.M., Barriga, Susana, Cox, Joanne, Goetz, Matthew
Published in The oncologist (Dayton, Ohio) (01.01.2021)
Published in The oncologist (Dayton, Ohio) (01.01.2021)
Get full text
Journal Article
Adjuvant abemaciclib for high-risk early breast cancer (EBC): Factors increasing the rate of treatment discontinuations in monarchE
Tolaney, Sara M., Johnston, Stephen R.D., Wei, Ran, Andre, Valerie AM, Shahir, Ashwin, Harbeck, Nadia, Martin, Miguel
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
In Reply
Rugo, Hope S, Huober, Jens, Garcia-Saenz, Jose A, Masuda, Norikazu, Sohn, Joo Hyuk, Andre, Valerie A M, Barriga, Susana, Cox, Joanne, Goetz, Matthew
Published in The oncologist (Dayton, Ohio) (01.07.2021)
Published in The oncologist (Dayton, Ohio) (01.07.2021)
Get full text
Journal Article
In Reply
Rugo, Hope S, Huober, Jens, Garcia-Saenz, Jose A, Masuda, Norikazu, Sohn, Joo Hyuk, Andre, Valerie A M, Barriga, Susana, Cox, Joanne, Goetz, Matthew
Published in The oncologist (Dayton, Ohio) (07.04.2021)
Get full text
Published in The oncologist (Dayton, Ohio) (07.04.2021)
Journal Article
Impact of abemaciclib on the time to subsequent chemotherapy and the time to second disease progression across the MONARCH 2 and 3 studies
Tolaney, Sara M., Di Leo, Angelo, Llombart Cussac, Antonio, Dickler, Maura N., Campone, Mario, Iwata, Hiroji, Toi, Masakazu, Kaufman, Peter A., Andre, Valerie AM, Barriga, Susana, Goetz, Matthew P., Sledge, George W.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article